PR Newswire
PharmAbcine Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology
April 26, 2022
DAEJEON, South Korea, April 26, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today the appointment of Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS to its Scientific Advisory Board. "We are very honored to have Professor Nguyen as a new member to our Scientific Advisory Board," commented Dr. Jin-San Yoo, CEO of PharmAbcine. "Professo